liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Individually dose-adjusted treatment with epirubicin and paclitaxel with or without capecitabine as 1st line treatment in metastatic breast cancer. A randomized multicenter trial in EJC SUPPLEMENTS, vol 8, issue 3, pp 195-196
Karolinska University Hospital.
Sahlgrens University Hospital.
Linköping University, Department of Clinical and Experimental Medicine, Oncology . Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Centre of Surgery and Oncology, Department of Oncology UHL.
Helsingborg Hospital.
Show others and affiliations
2010 (English)In: EJC SUPPLEMENTS, Elsevier Science B.V., Amsterdam. , 2010, Vol. 8, no 3, 195-196 p.Conference paper (Refereed)
Abstract [en]


Place, publisher, year, edition, pages
Elsevier Science B.V., Amsterdam. , 2010. Vol. 8, no 3, 195-196 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-58652ISI: 000276756900486OAI: diva2:344881
Available from: 2010-08-22 Created: 2010-08-20 Last updated: 2010-08-22

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Walz, Thomas
By organisation
Oncology Faculty of Health SciencesDepartment of Oncology UHL
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 25 hits
ReferencesLink to record
Permanent link

Direct link